Solriamfetol Hydrochloride
Overview
Solriamfetol Hydrochloride is a norepinephrine-dopamine reuptake inhibitor that is indicated to improve wakefulness in adult patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. It is known for its effects in enhancing the neurotransmission processes within the central nervous system, promoting alertness.
API suppliers (6)
Suppliers of Solriamfetol Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
5 of 6 hold a GMP certificate on record in the EU or UK registers
- ALIVUS LIFE SCIENCES LTDIndia1 active DMF GMP on record
- Unichem Laboratories Ltd.India1 active DMF GMP on record
- Alkem Laboratories LimitedIndia1 active DMF GMP on record
- Hikma Pharmaceuticals Usa IncUnited Kingdom1 active DMF
- APITORIA PHARMA PRIVATE LTDIndia1 active DMF GMP on record
- Hetero Drugs LimitedIndia1 active DMF GMP on record
Therapeutic areas
Do you supply Solriamfetol Hydrochloride? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.